Recent studies have shown that several protein kinases, like cyclin-dependent kinase 1 (CDK1) [15,16,17,18], play a significant role in pancreatic cancer resistance by modifying proteins involved in key signaling pathways. This evidence concerns the gene CDK1 and familial pancreatic carcinoma.